Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-13-061962

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 14, 2013 21.63M sh
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$436.5K
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$1.28M
Stockholders Equity Q3 2013 · Sep 30, 2013 −$2.75M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$1.68M
Current Liabilities Q3 2013 · Sep 30, 2013 $2.91M
Current Liabilities Q3 2013 · Dec 31, 2012 $2.25M
Current Assets Q3 2013 · Sep 30, 2013 $160.41K
Current Assets Q3 2013 · Dec 31, 2012 $571.8K
Total Assets Q3 2013 · Sep 30, 2013 $160.89K
Total Assets Q3 2013 · Dec 31, 2012 $575.27K
Cash And Equivalents Q3 2013 · Sep 30, 2012 $787.06K
Cash And Equivalents Q3 2013 · Dec 31, 2011 $2.13M
Sga Expense Q3 2013 · Sep 30, 2012 $228.45K
Sga Expense Q3 2013 · Sep 30, 2012 $641.31K
Rd Expense Q3 2013 · Sep 30, 2012 $248.65K
Rd Expense Q3 2013 · Sep 30, 2012 $888.88K
Net Income Q3 2013 · Sep 30, 2012 −$369K
Net Income Q3 2013 · Sep 30, 2012 −$1.28M
Operating Income Q3 2013 · Sep 30, 2012 −$477.1K
Operating Income Q3 2013 · Sep 30, 2012 −$1.53M
Revenue Q3 2013 · Sep 30, 2012 $0
Revenue Q3 2013 · Sep 30, 2012 $0